Nevakar announces formation of ophthalmic subsidiary, Vyluma
May 26, 2021
Vyluma Inc. will focus on the development and commercialization of therapies to treat ophthalmic diseases, including pediatric myopia.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Pediatrics
Unlocking the keys to mild COVID-19 cases in infants
June 18, 2021
According to investigators, infants may have an edge over adults, with babies demonstrating a stronger immune response to the SARS-CoV-2 virus.
Physician shines spotlight on mass distribution of azithromycin for trachoma control
May 21, 2021
Investigators find increased treatment regimen is effective and long-lasting for patients.
It takes a village to beat visual system diseases in children
January 28, 2021
Community involvement, research continue to boost treatment in pediatric population.
Gene therapy surgical pearls for successful outcomes
January 04, 2021
Nine pediatric patients with Leber congenital amaurosis show visual improvement in clinical trials.
Looking to the future of pediatric ophthalmology
November 02, 2020
New paradigm-changing treatments for young patients on the horizon.